Get the Stockscreener App
1.10
15.12%
0.1445
After Hours:
1.12
0.02
+1.82%
Onconetix Inc stock is traded at $1.10, with a volume of 2.35M.
It is up +15.12% in the last 24 hours and up +6.80% over the past month.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.
See More
Previous Close:
$0.9555
Open:
$1.01
24h Volume:
2.35M
Relative Volume:
1.95
Market Cap:
$4.06M
Revenue:
$735.20K
Net Income/Loss:
$-9.70M
P/E Ratio:
-0.00252
EPS:
-435.729
Net Cash Flow:
$-9.80M
1W Performance:
+15.27%
1M Performance:
+6.80%
6M Performance:
-98.74%
1Y Performance:
-99.53%
1-Day Range:
$0.98
$1.21
1-Week Range:
$0.9061
$1.21
52-Week Range:
$0.88
$270.00
Onconetix Inc Stock (ONCO) Company Profile
Name
Onconetix Inc
Sector
Industry
Phone
513-620-4101
Address
201 E. FIFTH STREET, CINCINNATI
Compare ONCO vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ONCO
Onconetix Inc
|
1.10 | 4.17M | 735.20K | -9.70M | -9.80M | -435.73 |
VRTX
Vertex Pharmaceuticals Inc
|
529.59 | 126.07B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
649.81 | 65.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
916.80 | 57.70B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
313.04 | 40.19B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
189.99 | 39.82B | 742.00K | -1.37B | -1.07B | -7.0731 |
Onconetix Inc Stock (ONCO) Latest News
Why Is Onco Micro-Cap Stock Surging 50% In Premarket? - Stocktwits
Price to sales forward of Onconetix, Inc. – NASDAQ:ONCO - TradingView
Price to book forward of Onconetix, Inc. – NASDAQ:ONCO - TradingView
Enterprise value to EBITDA forward of Onconetix, Inc. – NASDAQ:ONCO - TradingView
Enterprise value to revenue forward of Onconetix, Inc. – NASDAQ:ONCO - TradingView
Onconetix, Inc. (ONCO) Stock Price, News, Quote & History - Yahoo Finance
ONCO Stock Price, Quote & Chart - ChartMill
Onconetix Inc (ONCO) Institutional Confidence - TradingKey
Onconetix Inc (ONCO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Onconetix Announces Realbotix Optio and M-Series Humanoid Robot Pilot at Salamanca City Central School District - Quiver Quantitative
Onconetix (ONCO) agrees to buy Realbotix; Optio robot pilot to reach ~500 students - Stock Titan
A robot and AI tutor are headed to a New York school district - Stock Titan
ONCOOnconetix Inc Forecast, Target Price - Finviz
Onconetix Inc (ONCO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Onconetix Inc (ONCO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Onconetix Inc (ONCO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Onconetix Inc (ONCO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Onconetix Inc (ONCO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Onconetix Inc (ONCO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Onconetix Inc (ONCO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Onconetix (NASDAQ: ONCO) registers 100M shares; Keystone ELOC could deliver $25M - Stock Titan
[EFFECT] Onconetix, Inc. SEC Filing - Stock Titan
Onconetix Plans Reverse Stock Split to Bolster Share Price - timothysykes.com
ONCO News | ONCONETIX INC (NASDAQ:ONCO) - ChartMill
Onconetix Company Profile & Introduction - Moomoo
OnconetixRegisters Up To 100 Million Shares For Resale By Keystone Capital PartnersSEC Filing - TradingView
Onconetix (ONCO) files S-1 for 100M-share Keystone equity line amid going-concern risks - Stock Titan
Onconetix approves 1-for-10 reverse stock split effective May 21 - Investing.com UK
Humanoid robot maker Realbotix posts $442K income, plans Nasdaq listing - Stock Titan
Number of shareholders of Onconetix Inc – FWB:J4T - TradingView
Number of shareholders of Onconetix Inc – GETTEX:A42ANX - TradingView
Pretax income of Onconetix Inc – GETTEX:A42ANX - TradingView
Onconetix Inc (ONCO) Stock Price, Quote, News & History - Benzinga
Onconetix reverse split 10-to-1, aimed at Nasdaq $1 bid rule - Stock Titan
Onconetix Sets 1-for-10 Reverse Stock Split Effective - TipRanks
Onconetix (ONCO) enacts 1-for-10 reverse split to support Nasdaq listing - Stock Titan
What's going on in today's session - ChartMill
Which stocks are most active on Tuesday? - ChartMill
Onconetix approves 1-for-10 reverse stock split effective May 21 By Investing.com - Investing.com Australia
Let's take a look at the stocks that are in motion in today's session. - ChartMill
Realbotix Provides Update on Nasdaq Listing - Investing News Network
Onconetix, Inc. announces 1-for-10 reverse stock split - marketscreener.com
Onconetix: Split Intended to Enable Co to Maintain Compliance With Minimum Bid Price Requirement of $1/Shr of Common Stk for Continued Listing on Nasdaq Cap Market >ONCO - Moomoo
Realbotix provides update on Nasdaq listing - marketscreener.com
Onconetix, Inc. Announces 1-for-10 Reverse Stock Split - GlobeNewswire
Onconetix (ONCO) stock surges over 23% overnight: Why is it moving? - MSN
Onconetix shares jump 23.65% after clinical study boosts confidence in prostate cancer test Proclarix. - Pluang
Onconetix Inc Stock (ONCO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Onconetix Inc Stock (ONCO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | 10% Owner |
Apr 17 '26 |
Buy |
0.73 |
34,636 |
25,284 |
177,821 |
| HRT FINANCIAL LP | 10% Owner |
Apr 20 '26 |
Sale |
0.75 |
94,462 |
70,846 |
83,359 |
| HRT FINANCIAL LP | 10% Owner |
Apr 16 '26 |
Sale |
0.73 |
53,867 |
39,323 |
143,185 |
| HRT FINANCIAL LP | 10% Owner |
Apr 15 '26 |
Buy |
0.76 |
92,554 |
70,341 |
197,052 |
| HRT FINANCIAL LP | 10% Owner |
Apr 14 '26 |
Buy |
0.77 |
74,350 |
57,250 |
104,498 |
0.05%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):